Myocardial perfusion imaging methods and compositions
First Claim
Patent Images
1. A pharmaceutical composition comprising at least one A2a receptor agonist, at least one liquid carrier, and at least one co-solvent.
6 Assignments
0 Petitions
Accused Products
Abstract
A myocardial imaging method that is accomplished by administering one or more adenosine A2A adenosine receptor agonist to a human undergoing myocardial imaging as well as pharmaceutical compositions comprising at least one A2a receptor agonist, at least one liquid carrier, and at least one co-solvent.
156 Citations
61 Claims
- 1. A pharmaceutical composition comprising at least one A2a receptor agonist, at least one liquid carrier, and at least one co-solvent.
-
32. A method of producing coronary vasodilation without peripheral vasodilation comprising administering at least 10 μ
- g of at least one A2A receptor agonist to a human.
- View Dependent Claims (33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47)
- 48. A method of myocardial perfusion imaging of a human, comprising administering a radionuclide and a A2A receptor agonist to the human wherein the myocardium is examined for areas of insufficient blood flow following administration of the radionuclide and the A2A receptor agonist.
Specification